Meletios Athanasios Dimopoulos Selected Research

cilgavimab

9/2023

Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meletios Athanasios Dimopoulos Research Topics

Disease

19	Multiple Myeloma 04/2024 - 01/2004
9	Neoplasms (Cancer) 02/2024 - 10/2004
6	Waldenstrom Macroglobulinemia (Macroglobulinemia) 09/2021 - 08/2007
5	Immunoglobulin Light-chain Amyloidosis 08/2023 - 09/2015
4	Thrombocytopenia (Thrombopenia) 10/2023 - 11/2006
3	Cardiotoxicity 04/2024 - 10/2021
3	Breast Neoplasms (Breast Cancer) 04/2024 - 02/2022
3	Lymphoma (Lymphomas) 02/2024 - 01/2008
3	Neutropenia 10/2023 - 08/2007
3	COVID-19 09/2023 - 01/2021
3	Amyloidosis 04/2023 - 01/2009
2	Heart Failure 04/2024 - 09/2022
2	Inflammation (Inflammations) 04/2024 - 02/2024
2	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 04/2022
2	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 02/2022
2	Infections 11/2023 - 09/2023
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 04/2023 - 03/2022
2	Aortic Valve Stenosis (Aortic Stenosis) 04/2023 - 03/2022
2	Monoclonal Gammopathy of Undetermined Significance 01/2023 - 10/2004
2	Disease Progression 04/2022 - 09/2015
2	Cardiomyopathies (Cardiomyopathy) 10/2021 - 09/2015
2	Rare Diseases (Rare Disease) 09/2021 - 04/2021
2	Fatigue 01/2020 - 10/2014
2	Plasmacytoma 01/2020 - 01/2004
2	Renal Insufficiency (Renal Failure) 05/2008 - 04/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2024
1	Left Ventricular Dysfunction 04/2024
1	Carcinogenesis 02/2024
1	Fanconi Syndrome (Syndrome, Fanconi) 11/2023
1	Hypokalemia 11/2023
1	Chronic Hepatitis B 11/2023
1	Sepsis (Septicemia) 10/2023
1	Pain (Aches) 09/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2023
1	Type 2 Diabetes Mellitus (MODY) 03/2023
1	Thrombophilia 01/2023
1	Arthralgia (Joint Pain) 04/2022
1	Cholangiocarcinoma 04/2021
1	Amyloid Plaque 08/2020
1	Frailty 08/2020
1	Residual Neoplasm 08/2020

Drug/Important Bio-Agent (IBA)

7	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 04/2007
7	Bortezomib (Velcade)FDA Link 02/2022 - 04/2007
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
4	carfilzomibIBA 04/2024 - 10/2021
4	Rituximab (Mabthera)FDA Link 09/2021 - 08/2007
3	Proteasome InhibitorsIBA 10/2023 - 10/2021
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2006
3	Amyloid (Amyloid Fibrils)IBA 01/2023 - 09/2015
3	Immunoglobulin M (IgM)IBA 09/2021 - 01/2009
3	PanobinostatIBA 01/2020 - 10/2014
2	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 10/2021
2	Atorvastatin (Lipitor)FDA Link 04/2024 - 03/2024
2	Cyclin-Dependent Kinase 4IBA 04/2024 - 02/2024
2	Immune Checkpoint InhibitorsIBA 03/2024 - 02/2022
2	pomalidomideIBA 03/2024 - 10/2023
2	Immunomodulating AgentsIBA 03/2024 - 01/2018
2	Monoclonal AntibodiesIBA 09/2023 - 08/2007
2	AntibodiesIBA 09/2023 - 01/2019
2	GadoliniumIBA 04/2023 - 03/2022
2	Prealbumin (Transthyretin)IBA 04/2023 - 09/2015
2	Bevacizumab (Avastin)FDA Link 04/2022 - 02/2012
2	fludarabineIBA 01/2017 - 01/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 08/2007
2	CreatinineIBA 05/2008 - 11/2006
2	Thalidomide (Thalomid)FDA Link 04/2007 - 01/2004
1	pembrolizumabIBA 03/2024
1	Hormones (Hormone)IBA 02/2024
1	ribociclibIBA 02/2024
1	InflammasomesIBA 02/2024
1	Tenofovir (Viread)FDA Link 11/2023
1	NucleotidesIBA 11/2023
1	tenofovir alafenamideIBA 11/2023
1	Reverse Transcriptase InhibitorsIBA 11/2023
1	belantamab mafodotinIBA 10/2023
1	Lenalidomide (CC 5013)FDA Link 10/2023
1	tixagevimabIBA 09/2023
1	VaccinesIBA 09/2023
1	Neutralizing AntibodiesIBA 09/2023
1	cilgavimab and tixagevimab drug combinationIBA 09/2023
1	Messenger RNA (mRNA)IBA 09/2023
1	cilgavimabIBA 09/2023
1	mRNA VaccinesIBA 03/2023
1	BNT162 VaccineIBA 03/2023
1	pro-brain natriuretic peptide (1-76)IBA 09/2022
1	Clostridium perfringens epsilon-toxinIBA 09/2022
1	DiureticsIBA 09/2022
1	Methotrexate (Mexate)FDA LinkGeneric 04/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2022
1	ixazomibIBA 02/2022
1	ibrutinibIBA 09/2021
1	B7-H1 AntigenIBA 04/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 01/2020
1	CannabinoidsIBA 01/2020

Therapy/Procedure

13	Therapeutics 04/2024 - 07/2006
5	Drug Therapy (Chemotherapy) 03/2024 - 10/2004
2	Immunotherapy 02/2022 - 04/2021
1	Precision Medicine 04/2021